Cargando…

Treatment Outcomes of Re-irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection

Background and Purpose: Majority of patients with locoregionally recurrent rectal cancer will require re-irradation (reRT). This study aimed to analyze the treatment outcomes, particularly infield progression, and severe late toxicity rates after reRT for recurrent rectal cancer and further identify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Seung Yeun, Koom, Woong Sub, Keum, Ki Chang, Chang, Jee Suk, Shin, Sang Joon, Ahn, Joong Bae, Min, Byung Soh, Lee, Kang Young, Kim, Nam Kyu, Yoon, Hong In
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593136/ https://www.ncbi.nlm.nih.gov/pubmed/31275858 http://dx.doi.org/10.3389/fonc.2019.00529

Ejemplares similares

The location of locoregional recurrence in pathologic T3N0, non-irradiated lower rectal cancer
por: Kim, Mi Sun, et al.
Publicado: (2013)

Comparison of clinical outcomes between carbon ion radiotherapy and X-ray radiotherapy for reirradiation in locoregional recurrence of rectal cancer
por: Chung, Seung Yeun, et al.
Publicado: (2022)

Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases
por: Shin, Sang Joon, et al.
Publicado: (2011)

The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study
por: Kim, Jun Won, et al.
Publicado: (2010)

Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid–upper rectal cancer
por: Choi, Seo Hee, et al.
Publicado: (2017)

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
por: Kim, Kyung Hwan, et al.
Publicado: (2013)

Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner
por: Chang, Jee Suk, et al.
Publicado: (2013)

Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
por: Kim, Young Suk, et al.
Publicado: (2012)

Comparison of elective inguinal node irradiation techniques in anal cancer
por: Cha, Jihye, et al.
Publicado: (2011)

Vertebral compression fractures after spine irradiation using conventional fractionation in patients with metastatic colorectal cancer
por: Rhee, Woo Joong, et al.
Publicado: (2014)

MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection
por: Kim, Honsoul, et al.
Publicado: (2016)

Nomogram for prediction of pathologic complete remission using biomarker expression and endoscopic finding after preoperative chemoradiotherapy in rectal cancer
por: Hur, Hyuk, et al.
Publicado: (2020)

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
por: Kim, Chang Gon, et al.
Publicado: (2017)

Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer
por: Cho, Min Soo, et al.
Publicado: (2023)

Simple calculation using anatomical features on pre-treatment verification CT for bladder volume estimation during radiation therapy for rectal cancer
por: Kim, Nalee, et al.
Publicado: (2020)

Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis
por: Lee, Jii Bum, et al.
Publicado: (2021)

Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer
por: Yang, Gowoon, et al.
Publicado: (2022)

MR prediction of pathologic complete response and early-stage rectal cancer after neoadjuvant chemoradiation in patients with clinical T1/T2 rectal cancer for organ saving strategy
por: Bae, Heejin, et al.
Publicado: (2020)

Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors
por: Yoon, Hong In, et al.
Publicado: (2016)

Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
por: Lee, Jii Bum, et al.
Publicado: (2020)

A practical review of watch-and-wait approach in rectal cancer
por: Byun, Hwa Kyung, et al.
Publicado: (2023)

Evaluating Variations of Bladder Volume Using an Ultrasound Scanner in Rectal Cancer Patients during Chemoradiation: Is Protocol-Based Full Bladder Maintenance Using a Bladder Scanner Useful to Maintain the Bladder Volume?
por: Yoon, Hong In, et al.
Publicado: (2015)

Morphologic change of rectosigmoid colon using belly board and distended bladder protocol
por: Cho, Yeona, et al.
Publicado: (2015)

Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
por: Kim, Chang Gon, et al.
Publicado: (2016)

Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea
por: Chang, Jee Suk, et al.
Publicado: (2018)

Effect of Radiotherapy Combined With Pembrolizumab on Local Tumor Control in Mucosal Melanoma Patients
por: Kim, Hyun Ju, et al.
Publicado: (2019)

Impact of neoadjuvant treatment on rectal gastrointestinal stromal tumors
por: Cheong, Chinock, et al.
Publicado: (2022)

Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View
por: Kim, Hyun Ju, et al.
Publicado: (2021)

Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study
por: Sumita, Kiyomi, et al.
Publicado: (2016)

Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer
por: Yang, Wen-Chi, et al.
Publicado: (2020)

Risk stratification of abdominopelvic failure for FIGO stage III epithelial ovarian cancer patients: implications for adjuvant radiotherapy
por: Chang, Jee Suk, et al.
Publicado: (2013)

Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy
por: Lee, Jeongshim, et al.
Publicado: (2020)

Feasibility of carbon‐ion radiotherapy for re‐irradiation of locoregionally recurrent, metastatic, or secondary lung tumors
por: Hayashi, Kazuhiko, et al.
Publicado: (2018)

Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis
por: Zhao, Kaikai, et al.
Publicado: (2020)

Classification and Locoregional Treatment of Rectal Neuroendocrine Tumors
por: Singh, Gurdeep, et al.
Publicado: (2023)

Superior Effect of the Combination of Carbon-Ion Beam Irradiation and 5-Fluorouracil on Colorectal Cancer Stem Cells in vitro and in vivo
por: Koom, Woong Sub, et al.
Publicado: (2020)

Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
por: Chang, Jee Suk, et al.
Publicado: (2015)

Clinical outcomes for T(1-2)N(0-1 )oral tongue cancer patients underwent surgery with and without postoperative radiotherapy
por: Shim, Su Jung, et al.
Publicado: (2010)

Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible
por: Dijkstra, Esmée A., et al.
Publicado: (2021)

Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis
por: Hong, Liang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_17mmkos2958vksjn1p4tqd8hi2